Avanos (AVNS): שווי פעילות לרווח לפני ריבית, מסים ופחת

Avanos Medical, Inc. (AVNS) produces pain management and nutrition systems, relying on surgical volumes and component costs. The shift in the EV/EBITDA multiple clearly demonstrates financial stability, where the 16.57 level captures the latest values. A network of sterile plants guarantees supply stability, while the transition to outpatient care and the introduction of new devices drive organic growth of the customer base.

The EV/EBITDA multiple determines the total enterprise value, including net debt, relative to operating profit, excluding the impact of tax policy and depreciation. By analyzing the EV/EBITDA valuation trend, an investor can compare the market value of Avanos Medical, Inc. (AVNS) with its ability to generate cash flow from the supply of critical consumables, which confirms the asset's resilience amid any market volatility.